EcoDrugPlus

Toll Like Receptor 8

Ensembl ID : ENSPNAG00000008909
Gene Symbol: TLR8
1 Cross references
186 Possible Orthologues:

Trace Amine-Associated Receptor 1-Like

Ensembl ID : ENSPNAG00000022272
Gene Symbol: LOC108432867
3 Cross references
149 Possible Orthologues:

Transient Receptor Potential Cation Channel Subfamily A Member 1

Ensembl ID : ENSPNAG00000006764
Gene Symbol: TRPA1
3 Cross references
200 Possible Orthologues:

Transient Receptor Potential Cation Channel Subfamily A Member 1-Like

Ensembl ID : ENSPNAG00000019107
Gene Symbol: LOC108435699
3 Cross references
155 Possible Orthologues:

Transthyretin

Ensembl ID : ENSPNAG00000028049
Gene Symbol: TTR
3 Cross references
178 Possible Orthologues:

Tryptophan 5-Hydroxylase 1-Like

Ensembl ID : ENSPNAG00000014954
Gene Symbol: LOC108430795
3 Cross references
176 Possible Orthologues:

Tryptophan Hydroxylase 1

Ensembl ID : ENSPNAG00000007639
Gene Symbol: TPH1
3 Cross references
213 Possible Orthologues:

Tubulin Alpha 4a

Ensembl ID : ENSPNAG00000011606
Gene Symbol: TUBA4A
4 Cross references
143 Possible Orthologues:

Tubulin Alpha Chain-Like

Ensembl ID : ENSPNAG00000018851
Gene Symbol: LOC108411703
3 Cross references
130 Possible Orthologues:

Tubulin Alpha-1c Chain

Ensembl ID : ENSPNAG00000008681
Gene Symbol: LOC108431527
3 Cross references
78 Possible Orthologues:

Tubulin Beta 1 Class Vi

Ensembl ID : ENSPNAG00000005981
Gene Symbol: TUBB1
3 Cross references
184 Possible Orthologues:

Tubulin Beta 3 Class Iii

Ensembl ID : ENSPNAG00000028087
Gene Symbol: TUBB3
4 Cross references
147 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).